KCNN4 and cancer: Importantly, the expression levels of KCNN4 were significantly higher in stage III-IV patients than in stage I-II patients in THCA and KIRC cancers, suggesting that KCNN4 may reflect the clinical progression of these two tumors (Figure 6C).